Co-founders Mike Ushakov, Eugene Molodkin, and Nikita Shulaev are helping ease the burden of diabetes by combining meal tracking and CGM data in an elegantly-designed, clinically-validated app experience. — Challenge When a person has Type 1 diabetes (T1D), they live in a cycle of constant healthcare decision making. They’re constantly dealing with insulin while taking into account current blood glucose levels and recent and upcoming physical activity. …

Other funding this week went to health startups focused on virtual medical training, patient engagement, healthcare administration, and more. — This week’s reported health innovation funding included: BenchSci, a Toronto, ON-based developer of AI solutions for drug discovery, raised C$95M ($70M) led by Generation Investment Management, with participation from iNovia Capital, TCV, Golden Ventures, and F-Prime Capital. <source>

Meet the first 11 T1D Moonshot Fellowship recipients who are working to speed up progress on the prevention, management, and cure of Type 1 diabetes. — Earlier this year, StartUp Health announced a program-related investment (PRI) by The Helmsley Charitable Trust to provide education, support, and investment to scientists, entrepreneurs, and innovators who are working on the prevention, management, and cure of Type 1 diabetes (T1D). With Helmsley’s philanthropic support, 25 to 30 early-stage T1D startups…

This “digital-first early identification and guidance platform” seeks to give patients greater ownership of their health and wellbeing. By combining comprehensive data consolidation with AI-driven predictive analytics, this startup helps patients better identify potential conditions and then suggests appropriate healthcare next steps. — Challenge While electronic health records (EHR) are becoming more the norm in the United States, medical information for an individual is still scattered across numerous systems. This results in healthcare providers having access to an inaccurate and incomplete picture of a patient’s state of health when they seek treatment. Many care…

This week’s global health innovation funding also went to Paris-based robotics, Cleveland-based augmented reality, Singapore-based telehealth, and much more. — This week’s reported health innovation funding included: Patient21, a Berlin, Germany-based digi-physical healthtech company, raised €100M (~$108M) led by Pitango, with participation from Bertelsmann Investments, Artian, Target Global, Piton Capital, PICO Venture Partners, and angel investors, including Mario Kohle and Maria Raga. <source>

Founder Yusuf Henriques and Chief Scientific Officer Bradford Wilson, PhD, have combined their experience at the FDA, in the military, and in academia to drive the development of therapeutics that are effective in underrepresented populations. — Challenge While COVID-19 was devastating across the globe, it was particularly damaging for communities of color. African American, Latino, and Native American populations experienced disproportionately higher rates of infection and death than their European-American counterparts during the pandemic. This was in part due to underlying inequities in healthcare and increased exposure…

Our Health Transformer Showcases feature entrepreneurs who are upgrading healthcare delivery in every sector. April’s inspirational presenters are increasing access to care in underserved global markets, enhancing the healthcare experience, preventing blood sugar spikes, and improving pelvic health. — On Apr 27, 2023, a select group of participants spent an hour meeting inspirational entrepreneurs from the StartUp Health portfolio who are working to achieve health moonshots that will improve the health and wellbeing of people around the world.

The seed funding expands the StartUp Health portfolio company’s care navigation software and partnerships with a focus on addressing social determinants of health with cultural competency. — Pear Suite, a StartUp Health portfolio company working to empower community health workers and better address the social determinants of health (SDOH), announced the closing of $2.5M in seed funding. The funding will enable the Honolulu, HI-based company to support community health workers to better act on SDOH data as…

Our long relationship with Cyclica has provided us with invaluable insights into the transformative power of AI in healthcare. As we look ahead, we are more convinced than ever that AI is different — it is not just another technology, but a catalyst for unprecedented advancements that will reshape the future of healthcare, improving patient outcomes and revolutionizing the way we approach medical research and treatment.